Could nerve damage protect stomachs from popular diabetes drug?
NCT ID NCT07156591
Summary
This study aims to understand if diabetic nerve damage changes the risk of a slow-emptying stomach for people taking the diabetes/weight-loss drug semaglutide. Researchers will observe 460 patients with type 2 diabetes who are taking semaglutide and scheduled for an upper endoscopy. They will compare stomach contents during the procedure between patients with and without nerve damage to see if one group has a higher risk of food or liquid remaining.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC RETENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huadong hospital, Fudan university
Shanghai, Shanghai Municipality, 200040, China
Conditions
Explore the condition pages connected to this study.